THE FOUNDATION FIGHTING BLINDNESS INC
EIN: 23-7135845Columbia, MDZIP: 21045
H410 - Medical Research501(c)(3)
Mission
TO DRIVE THE RESEARCH THAT WILL PROVIDE PREVENTIONS, TREATMENTS AND CURES, FOR PEOPLE AFFECTED BY RETINITIS PIGMENTOSA, MACULAR DEGENERATION, USHER SYNDROME, AND THE SPECTRUM OF RETINAL DEGENERATIVE DISEASES.
Financials
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $36.6M | $0 | $110.9M |
| 2023 | $35.7M | $0 | $124M |
Compensation
2024
CHAD R JACKSON - SR DIR
$183,086
$24,318
$161
$225,004
2023
MICHELE C DIVINCENZO
$177,695
$20,900
$694
$248,184
CHAD R JACKSON
$176,521
$20,920
$152
$213,824
Explore related organizations
Similar Organizations
AMERICAN UROLOGICAL ASSOCIATION
$35.4M revenueLinthicum Hts, MD
Similar sector (H)Very similar revenue ($35.4M vs $36.6M)Same state (Maryland)Comparable compensation levels
THE LIEBER INSTITUTE INC
$28.9M revenueBaltimore, MD
Similar sector (H)Similar revenue ($28.9M vs $36.6M)Same state (Maryland)Comparable compensation levels
NEW YORK STEM CELL FOUNDATION INC
$30.4M revenueNew York, NY
Similar sector (H)Similar revenue ($30.4M vs $36.6M)Similar median compensation ($323k vs $301k)
LICR FUND INC
$34M revenueNew York, NY
Similar sector (H)Very similar revenue ($34M vs $36.6M)
TRANSCELERATE BIOPHARMA INC
$34.2M revenueWest Conshohocken, PA
Similar sector (H)Very similar revenue ($34.2M vs $36.6M)
LEDUCQ FOUNDATION
$34.8M revenueHouston, TX
Similar sector (H)Very similar revenue ($34.8M vs $36.6M)
DELTA HEALTH ALLIANCE INC
$37.2M revenueStoneville, MS
Similar sector (H)Very similar revenue ($37.2M vs $36.6M)
ALZHEIMER'S DISEASE RESEARCH FOUNDATION
$37.7M revenueWellesley Hills, MA
Similar sector (H)Very similar revenue ($37.7M vs $36.6M)
CONQUER CANCER FOUNDATION OF THE
$39.1M revenueAlexandria, VA
Similar sector (H)Very similar revenue ($39.1M vs $36.6M)
American Cancer Society Cancer Action
$45.5M revenueWashington, DC
Similar sector (H)Similar revenue ($45.5M vs $36.6M)Similar median compensation ($288k vs $301k)
Data from IRS Form 990 filings (2023-2024).